Scarica l'app Stockscreener
0.2717
2.28%
-0.0051
Fibrobiologics Inc Borsa (FBLG) Ultime notizie
Does FibroBiologics Inc (FBLG) offer a good opportunity for investors? - Setenews
FibroBiologics announces payoff of outstanding debt - MSN
Will FibroBiologics Inc. (SG0) stock deliver stable dividendsRisk Management & Expert Approved Momentum Trade Ideas - Newser
FibroBiologics prices 4.48M shares at 33.5c in registered direct offering - MSN
Is FibroBiologics Inc. (SG0) stock good for long term investingQuarterly Growth Report & Technical Pattern Recognition Alerts - Newser
Is FibroBiologics Inc. stock dividend yield sustainableWeekly Trade Summary & Verified Momentum Watchlists - Newser
Is FibroBiologics Inc. (SG0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - Newser
Prepare Yourself for Liftoff: FibroBiologics Inc (FBLG) - Setenews
Reviewing FibroBiologics (NASDAQ:FBLG) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Will FibroBiologics Inc. stock gain from strong economyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - BỘ NỘI VỤ
FibroBiologics repays convertible notes, eliminating dilution risk By Investing.com - Investing.com Nigeria
FibroBiologics Announces Payoff of Outstanding Debt - The Manila Times
FibroBiologics repays convertible notes, eliminating dilution risk - Investing.com
FibroBiologics (Nasdaq: FBLG) retires $15M Yorkville notes, keeps access to $25M SEPA - Stock Titan
FibroBiologics closes $1.5 million registered direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics announces closing of $1.5 million registered direct offering priced at-the-market under Nasdaq rules - marketscreener.com
Fibrobiologics Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - TradingView
FibroBiologics Closes $1.5 Million Registered Direct Share Offering - marketscreener.com
FibroBiologics closes $1.5 million registered direct offering - Investing.com
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
FibroBiologics Inc (FBLG) can make a big difference with a little luck - Setenews
FibroBiologics Announces Securities Purchase Agreement - TipRanks
FibroBiologics 8-K details equity raise with warrants and fees - Stock Titan
FibroBiologics raises $1.5 million in registered direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics stock tumbles after $1.5 million direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics stock tumbles after $1.5 million direct offering - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Fibrobiologics slides after unveiling $4 million registered direct offering financed with gold coins - MSN
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
FibroBiologics raises $1.5 million in registered direct offering - Investing.com
FibroBiologics (Nasdaq: FBLG) prices $1.5M direct offering at $0.335 with private warrants - Stock Titan
Will Naga Dhunseri Group Limited Stock Benefit From Industry Trends in YEARMarket Liquidity Analysis & Access Risk Ratings for Every Stock - earlytimes.in
FibroBiologics Inc Stock Analysis and ForecastHigh Yield Income Stocks & Capital Planning and Optimization - earlytimes.in
HC Wainwright & Co. Maintains FibroBiologics (FBLG) Buy Recommendation - MSN
Fibrobiologics receives Australian HREC approvals for CYWC-628 - BioWorld MedTech
FibroBiologics announces $25 million financing - MSN
Will FibroBiologics Inc. (SG0) stock outperform value peersJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
FibroBiologics (FBLG) Price Target Decreased by 14.63% to 8.92 - MSN
When is the best time to exit FibroBiologics Inc.Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
FibroBiologics prices 3.54M shares at 33c in registered direct offering - MSN
[424B5] FibroBiologics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
FibroBiologics (FBLG) Analyst Ratings: D. Boral Capital Maintains Buy | FBLG Stock News - GuruFocus
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - The Manila Times
Fibrobiologics receives HREC approval for phase 1/2 clinical trial for CYWC628 for the treatment of refractory diabetic foot ulcers - MarketScreener
FibroBiologics Receives HREC Approval for Phase 1/2 - GlobeNewswire
Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Oak Ridger
0.17%
1.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):